Glyconics is a diagnostics company, using infrared spectroscopy to analyse samples for markers of disease across a wide range of conditions.
Glyconics has raised €1.8M across 1 funding round from 3 investors, most recently a round in Nov 2021. Based in Cambridge, UK; active in Healthtech. Data as of 6 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-11-18 | Other | €1.8M |
| Boundary Capital,Deepbridge Capital,Wealth Club |
| View deal → |
